SCHEMBL25170241

SCHEMBL25170241

CC(C)(C)Oc1cc(F)cc(C(C)(C)C(=O)O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 2/20 0.41
▸ AKR1C2 P52895 2/20 0.41
▸ APP P05067 1/20 0.38
▸ CETP P11597 2/20 0.34
▸ PPARG P37231 1/20 0.34
▸ CYP4F2 P78329 1/20 0.33
▸ CYP4A11 Q02928 1/20 0.33
▸ CYP3A4 P08684 2/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ PPARA Q07869 1/20 0.32
▸ SCN9A Q15858 1/20 0.32
▸ S1PR2 O95136 2/20 0.31
▸ CNR1 P21554 2/20 0.31
▸ CNR2 P34972 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25460726 0.90 AKR1C3 (0.40) AKR1C3AKR1C2APPCETPPPARA
SCHEMBL30057746 0.90 AKR1C3 (0.40) AKR1C3AKR1C2APPCETPPPARA
SCHEMBL25168983 0.86 AKR1C3 (0.55) AKR1C3AKR1C2APPALOX5
SCHEMBL25175992 0.85 ALOX5 (0.39) AKR1C3AKR1C2CETPCYP4F2CYP4A11
SCHEMBL12079275 0.83 APP (0.45) AKR1C3AKR1C2APPCYP3A4CYP2C9
SCHEMBL6764250 0.78 SCN9A (0.36) CETPSCN9A
SCHEMBL18355357 0.77 CA12 (0.33) PPARGCYP4F2CYP4A11
SCHEMBL25173356 0.77 APP (0.51) AKR1C3AKR1C2APPMAPT
SCHEMBL25175855 0.77 APP (0.41) AKR1C3AKR1C2APPCYP3A4CYP2C9
SCHEMBL25170201 0.74 ALOX5 (0.38) PPARASCN9ACNR1CNR2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12281149-B2 Modulators of G-protein coupled receptors CARMOT THERAPEUTICS, INC. (US) 2025-04-22 — — US disclosed
US-20240383960-A1 Modulators of G-Protein Coupled Receptors CARMOT THERAPEUTICS INC. (US) 2024-11-21 — — US disclosed
CN-117980325-A Modulators of G-protein coupled receptors 卡莫特治疗学股份有限公司 2024-05-03 — — CN disclosed
EP-4337682-A2 MODULATORS OF G-PROTEIN COUPLED RECEPTORS Carmot Therapeutics Inc. (US) 2024-03-20 — — EP disclosed
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 — — US disclosed
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 — — US disclosed
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 — — US disclosed
WO-2022241287-A2 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. (US) 2022-11-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240383960-A1 Modulators of G-Protein Coupled Receptors GIPR, GLP1R, GCGR AKR1C3 3292/4885AKR1C2 2958/4885APP 1470/4885
US-12281149-B2 Modulators of G-protein coupled receptors GIPR, GLP1R, GCGR AKR1C3 3106/4885AKR1C2 2812/4885APP 1313/4885
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR AKR1C3 3106/4885AKR1C2 2812/4885APP 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback